Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
MRKR	Marker Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.55M	-$12.16M	-343.0%	-72.4%	-46.2%	-$0.79
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
CPHI	China Pharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.14M	-$3.19M	-76.9%	-14.0%	-8.5%	-$0.74
PRPH	ProPhase Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.34M	-$14.74M	-339.3%	-420.3%	-35.8%	-$1.74
ENSC	Ensysce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$10.18M	-200.8%	-316.6%	-2.8%	-$3.98
KRRO	Korro Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.39M	-$117.26M	n/m	-228.0%	181.5%	-$12.48
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
OVID	Ovid Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.25M	-$17.41M	-240.1%	-13.3%	n/m	n/a
XENE	Xenon Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.50M	-$345.91M	n/m	-59.5%	n/a	-$4.36
ADAG	Adagene Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.67M	-$17.61M	-229.6%	-49.8%	n/m	-$0.30
BOLT	Bolt Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.70M	-$33.38M	-433.7%	-125.9%	0.1%	-$17.85
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
BIOA	BioAge Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$8.99M	-$80.61M	-896.1%	-29.6%	n/a	-$2.24
ISCO	International Stem Cell Corp Manufacturing · Year ended 2025-12-31 · USD	$9.10M	-$418.0K	-4.6%	n/a	0.2%	-$0.05
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12

Rows per page: 2550 100